Revvity Overview
- Year Founded
-
1937
- Status
-
Public
- Employees
-
11,000
- Stock Symbol
-
RVTY
- Investments
-
71
- Share Price
-
$157.02
- (As of Thursday Closing)
Revvity General Information
Description
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
Contact Information
Website
www.revvity.comCorporate Office
- 77 4th Avenue
- Waltham, MA 02451-7567
- United States
Corporate Office
- 77 4th Avenue
- Waltham, MA 02451-7567
- United States
Revvity Stock Performance
As of 12-Nov-2026, Revvity’s stock price is $157.02. Its current market cap is $17.5B with 112M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $157.02 | $158.25 | $81.22 - $171.74 | $17.5B | 112M | 1.92M | $2.25 |
Revvity Financials Summary
As of 30-Sep-2026, Revvity has a trailing 12-month revenue of $2.94B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 19,379,018 | 13,406,707 | 15,668,541 | 16,073,874 |
| Revenue | 2,941,761 | 2,856,051 | 2,755,026 | 2,750,571 |
| EBITDA | 767,032 | 734,759 | 767,114 | 641,458 |
| Net Income | 253,201 | 241,201 | 270,385 | 693,094 |
| Total Assets | 11,490,346 | 12,168,411 | 12,392,478 | 13,564,665 |
| Total Debt | 2,765,032 | 3,398,207 | 3,325,805 | 4,065,295 |
Revvity Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Revvity Comparisons
Industry
Financing
Details
Revvity Competitors (21)
One of Revvity’s 21 competitors is Bio-Rad Laboratories, a Corporation company based in Hercules, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Bio-Rad Laboratories | Corporation | Hercules, CA | ||||
| GE HealthCare Technologies | Corporation | Chicago, IL | ||||
| Tecan Trading | Corporation | Mannedorf, Switzerland | ||||
| Idexx Laboratories | Formerly VC-backed | Westbrook, ME | ||||
| BioMérieux | Formerly PE-Backed | Marcy-l'Etoile, France |
Revvity Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Revvity Patents
Revvity Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026231724-A1 | Chemical analysis using rapid switching gas plasma | Pending | 29-Apr-2025 | ||
| WO-2026218017-A1 | Infrared microscopy system with height mapped imaging | Pending | 11-Apr-2025 | ||
| WO-2026187904-A1 | Multiple gas flow ionizer | Pending | 04-Mar-2025 | ||
| US-20240272122-A1 | Analyzing moisture sensitive/reactive gases | Inactive | 13-Feb-2023 | ||
| EP-4620267-A1 | Induction devices for inductively coupled plasma torches and methods and systems including same | Pending | 16-Nov-2022 | H05H1/30 |
Revvity Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Revvity Investments & Acquisitions (71)
Revvity’s most recent deal was a Merger/Acquisition with Human Cell Design. The deal was made on 09-Sep-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Human Cell Design | 09-Sep-2026 | Merger/Acquisition | Discovery Tools (Healthcare) | ||
| ACD/Labs | 15-Jan-2026 | Merger/Acquisition | Business/Productivity Software | ||
| Spring Discovery | 03-Mar-2025 | Merger/Acquisition | Other Healthcare Technology Systems | ||
| SonoVol | 07-Feb-2022 | Merger/Acquisition | Diagnostic Equipment | ||
| Virtue DX | 06-Jan-2022 | Early Stage VC | Laboratory Services (Healthcare) |
Revvity ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
17.57 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Laboratory Equipment and Services
Subindustry
of 67
Rank
Percentile
Revvity Exits (6)
Revvity’s most recent exit was on 01-Jan-2015 from Fluent Wave. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Fluent Wave | 01-Jan-2015 | Completed |
|
||
| Eurofins NTD | 27-Jul-2006 | Completed |
|
||
| Alara (Diagnostic Equipment) | 29-Oct-2003 | Completed |
|
||
| Alara (Diagnostic Equipment) | 06-Jun-2002 | Completed |
|
||
| Voltarc Technologies | 02-Oct-1997 | Merger/Acquisition | Completed |
Revvity Affiliates
Subsidiaries (13)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| SonoVol | Durham, NC | 2012 | |
| ArtusLabs | Durham, NC | 2007 | |
| Horizon Discovery | Cambridge, United Kingdom | 2005 | |
| Spectra Analysis Instruments | Marlborough, MA | 2004 | |
| Nexcelom Bioscience | Lawrence, MA | 2003 |
Revvity FAQs
-
When was Revvity founded?
Revvity was founded in 1937.
-
Where is Revvity headquartered?
Revvity is headquartered in Waltham, MA.
-
What is the size of Revvity?
Revvity has 11,000 total employees.
-
What industry is Revvity in?
Revvity’s primary industry is Diagnostic Equipment.
-
Is Revvity a private or public company?
Revvity is a Public company.
-
What is Revvity’s stock symbol?
The ticker symbol for Revvity is RVTY.
-
What is the current stock price of Revvity?
As of 12-Nov-2026 the stock price of Revvity is $157.02.
-
What is the current market cap of Revvity?
The current market capitalization of Revvity is $17.5B.
-
What is Revvity’s current revenue?
The trailing twelve month revenue for Revvity is $2.94B.
-
Who are Revvity’s competitors?
Bio-Rad Laboratories, GE HealthCare Technologies, Tecan Trading, Idexx Laboratories, and BioMérieux are some of the 21 competitors of Revvity.
-
What is Revvity’s annual earnings per share (EPS)?
Revvity’s EPS for 12 months was $2.25.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
